Medical–surgical integration ‘boosts neoadjuvant chemotherapy use for bladder cancer’
Research from the USA indicates that a multidisciplinary approach and coordination between medical and surgical oncology services can help optimize the use of neoadjuvant chemotherapy for bladder cancer.
No comments:
Post a Comment